Swiss National Bank’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-28,600
| Closed | -$239K | – | 2571 |
|
2023
Q3 | $239K | Hold |
28,600
| – | – | ﹤0.01% | 2597 |
|
2023
Q2 | $264K | Buy |
28,600
+6,600
| +30% | +$60.9K | ﹤0.01% | 2597 |
|
2023
Q1 | $302K | Sell |
22,000
-2,500
| -10% | -$34.4K | ﹤0.01% | 2607 |
|
2022
Q4 | $417K | Buy |
24,500
+1,800
| +8% | +$30.6K | ﹤0.01% | 2604 |
|
2022
Q3 | $516K | Buy |
22,700
+1,200
| +6% | +$27.3K | ﹤0.01% | 2556 |
|
2022
Q2 | $388K | Buy |
21,500
+3,000
| +16% | +$54.1K | ﹤0.01% | 2670 |
|
2022
Q1 | $495K | Buy |
18,500
+1,500
| +9% | +$40.1K | ﹤0.01% | 2607 |
|
2021
Q4 | $499K | Hold |
17,000
| – | – | ﹤0.01% | 2668 |
|
2021
Q3 | $1.12M | Buy |
17,000
+400
| +2% | +$26.3K | ﹤0.01% | 2379 |
|
2021
Q2 | $1.38M | Hold |
16,600
| – | – | ﹤0.01% | 2325 |
|
2021
Q1 | $1.27M | Buy |
16,600
+200
| +1% | +$15.3K | ﹤0.01% | 2256 |
|
2020
Q4 | $1.45M | Buy |
16,400
+300
| +2% | +$26.5K | ﹤0.01% | 2100 |
|
2020
Q3 | $1.19M | Hold |
16,100
| – | – | ﹤0.01% | 2000 |
|
2020
Q2 | $1.18M | Buy |
+16,100
| New | +$1.18M | ﹤0.01% | 2017 |
|